Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support

被引：39

作者：

Engmann, Lawrence ^{[1
]}

Benadiva, Claudio ^{[1
]}

机构：

[1] Univ Connecticut, Ctr Hlth, Ctr Adv Reprod Serv, Dept Obstet & Gynecol,Div Reprod Endocrinol & Inf, Farmington, CT 06030 USA

来源：

FERTILITY AND STERILITY | 2012年 / 97卷 / 03期

关键词：

GnRHa trigger; dual GnRHa trigger; OHSS; luteal phase support; low dose hCG supplementation; OVARIAN HYPERSTIMULATION SYNDROME; HUMAN CHORIONIC-GONADOTROPIN; FINAL OOCYTE MATURATION; LUTEINIZING-HORMONE SURGE; DOSE GNRH AGONIST; OVULATORY CHANGES; PRIMATE FOLLICLES; INHIBIN-A; HIGH-RISK; CYCLES;

D O I：

10.1016/j.fertnstert.2011.12.020

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Although gonadotropin-releasing hormone agonist (GnRHa) trigger is effective in the prevention of ovarian hyperstimulation syndrome, lower conception rates have been reported. Intensive luteal phase support is an effective approach to improve implantation rates in women with peak E-2 levels >= 4,000 pg/mL. However, patients with peak E-2 levels <4,000 pg/mL may require a dual trigger with GnRHa and 1,000 IU hCG and intensive luteal phase support to improve implantation rates. (Fertil Steril (R) 2012;97:531-3. (C) 2012 by American Society for Reproductive Medicine.)

引用

页码：531 / 533

页数：3

共 26 条

[1] Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates [J].

Acevedo, Belen ;

Gomez-Palomares, Jose Luis ;

Ricciarelli, Elisabetta ;

Hernandez, Eleuterio R. .

FERTILITY AND STERILITY, 2006, 86 (06) :1682-1687

[2] Serum inhibin A, VEGF and TNFα levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment:: a prospective randomized trial [J].

Babayof, R ;

Margalioth, EJ ;

Huleihel, M ;

Amash, A ;

Zylber-Haran, E ;

Gal, M ;

Brooks, B ;

Mimoni, T ;

Eldar-Geva, T .

HUMAN REPRODUCTION, 2006, 21 (05) :1260-1265

[3] Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment [J].

Beckers, NGM ;

Macklon, NS ;

Eijkemans, MJ ;

Ludwig, M ;

Felberbaum, RE ;

Diedrich, K ;

Bustion, S ;

Loumaye, E ;

Fauser, BCJM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09) :4186-4192

[4] TITRATING LUTEINIZING-HORMONE SURGE REQUIREMENTS FOR OVULATORY CHANGES IN PRIMATE FOLLICLES .2. PROGESTERONE-RECEPTOR EXPRESSION IN LUTEINZING GRANULOSA-CELLS [J].

CHANDRASEKHER, YA ;

BRENNER, RM ;

MOLSKNESS, TA ;

YU, Q ;

STOUFFER, RL .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (03) :584-589

[5] Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-1I, and their receptors in humans [J].

Cheng, CK ;

Leung, PCK .

ENDOCRINE REVIEWS, 2005, 26 (02) :283-306

[6]

Daya S, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001299, 10.1002/14641858.CD001299]

[7] The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study [J].

Engmann, Lawrence ;

DiLuigi, Andrea ;

Schmidt, David ;

Nulsen, John ;

Maier, Donald ;

Benadiva, Claudio .

FERTILITY AND STERILITY, 2008, 89 (01) :84-91

[8] GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS [J].

Engmann, Lawrence .

REPRODUCTIVE BIOMEDICINE ONLINE, 2006, 13 (05) :639-644

[9] Ovarian Hyperstimulation Syndrome Prevention Strategies: Luteal Support Strategies to Optimize Pregnancy Success in Cycles with Gonadotropin-Releasing Hormone Agonist Ovulatory Trigger [J].

Engmann, Lawrence ;

Benadiva, Claudio .

SEMINARS IN REPRODUCTIVE MEDICINE, 2010, 28 (06) :506-512

[10] DUAL TRIGGER OF OOCYTE MATURATION WITH GONADOTROPIN RELEASING HORMONE AGONIST (GnRHa) AND LOW DOSE HUMAN CHORIONIC GONADOTROPIN (hCG) TO OPTIMIZE CONCEPTION RATES IN HIGH RESPONDERS [J].

Griffin, D. W. ;

Benadiva, C. A. ;

Kummer, N. E. ;

Elassar, A. A. ;

Nulsen, J. C. ;

Engmann, L. L. .

FERTILITY AND STERILITY, 2011, 96 (03) :S20-S21

← 1 2 3 →